11:45 PM New York – Aecom fourth-quarter net surged to $88.5 million. Clementia Pharmaceuticals third-quarter net loss widened to $39 million. Tyson Foods fourth-quarter net fell 1% to $394 million. Viewray third-quarter net loss narrowed to $11 million.
Tollbooth Index edged down 8.10 to 13,294.50.
), the infrastructure developer reported revenues in the fourth-quarter ending in September soared 12% from a year ago to $4.9 billion.
Net income in the quarter surged to $88.5 million or 55 cents per diluted share from $7 million or 5 cents in the same quarter last year.
Aecom said in the year, the backlog soared to record $23.2 billion after the strong contributions from DCS Americas and Management services businesses and total backlog surged 11% to $47.5 billion from a year ago.
The infrastructure developer forecasted fiscal 2018 operating profit of about $910 million and earnings per share in the range of $2.50 to $2.90, reflecting strong growth compared to fiscal 2017.
Clementia Pharmaceuticals Inc
), the clinical stage biopharmaceutical drugs maker said net loss in the third-quarter ending in September widened to $39 million or $1.83 per diluted share from $1.6 million or 69 cents in the same quarter last year.
The Boeing Company
), the commercial aircrafts maker said in Dubai Air Show Emirates agreed to purchase 40 787-10 Dreamliners including airplanes and related equipment, is valued at $15.1 billion at list price and the deliveries of the aircraft are scheduled to start in 2022.
Meanwhile, Azerbaijan Airlines also order five more 787-8 Dreamliners and a commitment to purchase two large freighters in a deal valued at about $1.9 billion at current list prices.
Separately today The Boeing said Kuwait-based ALAFCO commercial aircraft leasing provider booked order for 20 additional 737 MAX 8s valued at $2.2 billion at current list prices.
Tyson Foods, Inc
), the food processor reported sales in the fourth-quarter ending in September soared 9.8% from a year ago to $10.1 billion.
Net income in the quarter fell 0.8% to $394 million or $1.07 per diluted share from $391 million or $1.03 in the same quarter last year.
Tyson Foods forecasted fiscal 2018 earnings per share between $5.70 and $5.85 and capital expenditures of about $1.4 billion and continue reduce the debt.
), the MRI-guided radiation therapy system developer said total revenues in the third-quarter ending in September soared from a year ago to $12.2 million.
Net loss in the quarter narrowed to $11.2 million or 19 cents per diluted share from $14.1 million or 35 cents in the same quarter last year.
In 2017, Viewray forecasted to deliver 7 to 8 MRIdian Linac Systems but adjusting total revenue to be in the range of $42 million to $47 million.